Literature DB >> 17268536

Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid.

J Vellinga1, J de Vrij, S Myhre, T Uil, P Martineau, L Lindholm, R C Hoeben.   

Abstract

Recombinant adenoviruses are frequently used as gene transfer vehicles for therapeutic gene delivery. Strategies to amend their tropism include the incorporation of polypeptides with high affinity for cellular receptors. Single-chain antibodies have a great potential to achieve such cell type specificity. In this study, we evaluated the efficiency of incorporation of a single-chain antibody fused with the adenovirus minor capsid protein IX in the capsid of adenovirus type 5 vectors. To this end, the codons for the single-chain antibody fragments (scFv) 13R4 were fused with those encoding of pIX via a 75-Angstrom spacer sequence. The 13R4 is a hyper-stable single-chain antibody directed against beta-galactosidase, which was selected for its capacity to fold correctly in a reducing environment such as the cytoplasm. A lentiviral vector was used to stably express the pIX.flag.75.13R4.MYC.HIS fusion gene in 911 helper cells. Upon propagation of pIX-gene deleted human adenovirus-5 vectors on these cells, the pIX-fusion protein was efficiently incorporated in the capsid. Here, the 13R4 scFv was functional as was evident from its capacity to bind its ligand beta-galactosidase. These data demonstrate that the minor capsid protein IX can be used as an anchor for incorporation of single-chain antibodies in the capsids of adenovirus vectors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17268536      PMCID: PMC2233715          DOI: 10.1038/sj.gt.3302908

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  35 in total

Review 1.  Stability engineering of antibody single-chain Fv fragments.

Authors:  A Wörn; A Plückthun
Journal:  J Mol Biol       Date:  2001-02-02       Impact factor: 5.469

2.  Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes.

Authors:  Françoise Carlotti; Merlijn Bazuine; Tuija Kekarainen; Jurgen Seppen; Philippe Pognonec; J Antonie Maassen; Rob C Hoeben
Journal:  Mol Ther       Date:  2004-02       Impact factor: 11.454

Review 3.  Gene therapy progress and prospects: adenoviral vectors.

Authors:  J A St George
Journal:  Gene Ther       Date:  2003-07       Impact factor: 5.250

4.  Direct in vivo screening of intrabody libraries constructed on a highly stable single-chain framework.

Authors:  Adrian Auf der Maur; Christian Zahnd; Franziska Fischer; Silvia Spinelli; Annemarie Honegger; Christian Cambillau; Dominik Escher; Andreas Plückthun; Alcide Barberis
Journal:  J Biol Chem       Date:  2002-09-04       Impact factor: 5.157

5.  Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability.

Authors:  Maria K Magnusson; Saw See Hong; Petra Henning; Pierre Boulanger; Leif Lindholm
Journal:  J Gene Med       Date:  2002 Jul-Aug       Impact factor: 4.565

6.  Selection for improved protein stability by phage display.

Authors:  S Jung; A Honegger; A Plückthun
Journal:  J Mol Biol       Date:  1999-11-19       Impact factor: 5.469

7.  Lentivirus vectors encoding both central polypurine tract and posttranscriptional regulatory element provide enhanced transduction and transgene expression.

Authors:  S C Barry; B Harder; M Brzezinski; L Y Flint; J Seppen; W R Osborne
Journal:  Hum Gene Ther       Date:  2001-06-10       Impact factor: 5.695

8.  The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells.

Authors:  A Sirven; F Pflumio; V Zennou; M Titeux; W Vainchenker; L Coulombel; A Dubart-Kupperschmitt; P Charneau
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

9.  Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments.

Authors:  Susan D Saban; Mariena Silvestry; Glen R Nemerow; Phoebe L Stewart
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

10.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences.

Authors:  A Follenzi; L E Ailles; S Bakovic; M Geuna; L Naldini
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

View more
  14 in total

1.  Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors.

Authors:  Di Yu; Chuan Jin; Justyna Leja; Nadim Majdalani; Berith Nilsson; Fredrik Eriksson; Magnus Essand
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity.

Authors:  Kathy L Poulin; Emily R McFall; Grace Chan; Natacha B Provost; Carin Christou; Adam C Smith; Robin J Parks
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

Review 3.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

4.  The C-terminal domains of adenovirus serotype 5 protein IX assemble into an antiparallel structure on the facets of the capsid.

Authors:  Céline M S Fabry; Manuel Rosa-Calatrava; Christine Moriscot; Rob W H Ruigrok; Pierre Boulanger; Guy Schoehn
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

Review 5.  Chapter two--Adenovirus strategies for tissue-specific targeting.

Authors:  Matthew S Beatty; David T Curiel
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

6.  Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.

Authors:  Julie L Boyer; Carolina Sofer-Podesta; John Ang; Neil R Hackett; Maria J Chiuchiolo; Svetlana Senina; David Perlin; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2010-07       Impact factor: 5.695

7.  Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.

Authors:  Kathy L Poulin; Robert M Lanthier; Adam C Smith; Carin Christou; Milagros Risco Quiroz; Karen L Powell; Ryan W O'Meara; Rashmi Kothary; Ian A Lorimer; Robin J Parks
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

8.  Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.

Authors:  Elena A Kashentseva; Joanne T Douglas; Kurt R Zinn; David T Curiel; Igor P Dmitriev
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

9.  Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer.

Authors:  Kristopher J Kimball; Angel A Rivera; Kurt R Zinn; Mert Icyuz; Vaibhav Saini; Jing Li; Zeng B Zhu; Gene P Siegal; Joanne T Douglas; David T Curiel; Ronald D Alvarez; Anton V Borovjagin
Journal:  Mol Imaging       Date:  2009 Sep-Oct       Impact factor: 4.488

10.  Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imaging.

Authors:  J Michael Mathis; Shilpa Bhatia; Alok Khandelwal; Imre Kovesdi; Stephen J Lokitz; Yoshi Odaka; Amol M Takalkar; Tracee Terry; David T Curiel
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.